Immusoft's Series A Round

Immusoft raised a round of funding on August 20, 2014.

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The first ISP-based treatment Immusoft will advance to h…

Articles about Immusoft's Series A Round: